Brief: BG Medicine says FDA made available 510(k) clearance for premarket notification number k140436
30/12/2014 11:50
Dec 30 (Reuters) - BG Medicine Inc BGMD.O : * On December 29, 2014, FDA made publicly available the 510(k) clearance for premarket notification number k140436 - SEC filing * Says the new assay will be commercialized through an agreement between BG Medicine and Abbott Laboratories * Source text for Eikon ID:nEOL9krVlb * Further company coverage BGMD.O ((Bengaluru Newsroom; +1 646 223 8780))
Recent news on BG Medicine
See all newsBrief: BG Medicine reports Q2 loss of $0.23 per share
Brief: BG Medicine announces proposed underwritten public offering
Brief: BG Medicine announces payoff of secured term loan
Brief: BG Medicine announces one-for-four reverse stock split
Brief: BG Medicine says co's largest customer of BGM galectin test filed for bankruptcy protection